CS
CVS icon

Credit Suisse’s CVS Health CVS Stock Holding History

Credit Suisse’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,168,100
Closed -$121M – 3750
2021
Q4 		$121M Buy
1,168,100
+16,900
+1% +$1.56M 0.06% 316
2021
Q3 		$97.7M Buy
1,151,200
+465,000
+68% +$38.9M 0.05% 378
2021
Q2 		$57.3M Buy
686,200
+84,800
+14% +$6.94M 0.03% 612
2021
Q1 		$45.2M Sell
601,400
-384,900
-39% -$28M 0.02% 753
2020
Q4 		$67.4M Buy
986,300
+188,800
+24% +$12.3M 0.03% 566
2020
Q3 		$46.6M Buy
797,500
+150,100
+23% +$9.34M 0.03% 638
2020
Q2 		$42.1M Sell
647,400
-255,000
-28% -$16.1M 0.03% 610
2020
Q1 		$53.5M Buy
902,400
+357,300
+66% +$23.9M 0.05% 412
2019
Q4 		$40.5M Buy
545,100
+120,100
+28% +$8.43M 0.03% 663
2019
Q3 		$26.8M Buy
425,000
+50,000
+13% +$2.96M 0.02% 751
2019
Q2 		$20.4M Sell
375,000
-613,900
-62% -$33.1M 0.02% 919
2019
Q1 		$53.3M Buy
988,900
+813,900
+465% +$50.2M 0.05% 401
2018
Q4 		$11.5M Buy
+175,000
New +$13.1M 0.01% 1082
2017
Q2 		– Sell
-125,000
Closed -$9.81M – 3847
2017
Q1 		$9.81M Buy
125,000
+80,000
+178% +$6.39M 0.01% 1234
2016
Q4 		$3.55M Buy
+45,000
New +$3.64M ﹤0.01% 1927
2016
Q3 		– Sell
-50,000
Closed -$4.79M – 4108
2016
Q2 		$4.79M Buy
+50,000
New +$4.98M 0.01% 1653
2015
Q2 		– Sell
-80,000
Closed -$8.26M – 4529
2015
Q1 		$8.26M Buy
+80,000
New +$8.09M 0.01% 1317
2013
Q4 		– Sell
-402,000
Closed -$22.8M – 4594
2013
Q3 		$22.8M Buy
402,000
+82,000
+26% +$4.89M 0.02% 678
2013
Q2 		$18.3M Buy
+320,000
New +$18.5M 0.02% 798

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse's CVS Position: Q1 2024 in Review

Credit Suisse reduced its CVS Health (CVS) stake by 5.3% in Q1 2024, selling an estimated $6.68M and leaving 1,549,136 shares worth $124M. The position accounts for 0.12% of the portfolio, ranked #155.

Credit Suisse first reported a position in CVS in Q2 2013 and has held it in 44 quarters since. The position peaked at $456M in Q4 2014. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Credit Suisse held 1,549,136 shares of CVS Health worth $124M as of Q1 2024.
  • Credit Suisse sold 87,468 CVS Health shares in Q1 2024, an estimated $6.68M.
  • CVS Health made up 0.12% of Credit Suisse's portfolio in Q1 2024, its #155 holding.
  • Credit Suisse first reported a position in CVS Health in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's CVS Health position peaked at $456M in Q4 2014.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.